Gespeichert in:
| Titel: | Drug Delivery and Targeting |
|---|---|
| Von: |
edited by Monika Schäfer-Korting, Ulrich S. Schubert.
|
| Person: |
Schäfer-Korting, Monika.
Schubert, Ulrich S. editor. |
| Körperschaft: | |
| Weitere beteiligte Personen: | , |
| Format: | Elektronisch E-Book |
| Sprache: | Englisch |
| Veröffentlicht: |
Cham :
Springer International Publishing : Imprint: Springer,
2024.
|
| Ausgabe: | 1st ed. 2024. |
| Schriftenreihe: | Handbook of Experimental Pharmacology,
284 |
| Schlagwörter: | |
| Medienzugang: | https://doi.org/10.1007/978-3-031-52864-4 |
| Zusammenfassung: | Since the publication of the Handbook of Experimental Pharmacology Vol. 197 in 2010 there have been important advances in drug development, drug delivery and - more recently - drug targeting. This is in particular relevant with the new generation of drugs acting on the immune system and tumors. These are quite often accompanied by major adverse reactions. Safe therapy is, therefore, an important area of research, in particular in chronic diseases and in persons of old age. In addition, the Covid-19 pandemic has brought renewed attention to vaccinations against viral infections, and mRNA vaccines have been tested for vaccination in tumor therapy, too. Vaccine delivery has stimulated important research on carriers which may pave the way for other applications and enhance a path to e.g. CRISPR-cas therapy. |
| Umfang: | 1 Online-Ressource (X, 411 p. 70 illus.) |
| ISBN: | 9783031528644 |
| ISSN: | 1865-0325 ; |
Internformat
MARC
| LEADER | 00000nam a22000005i 4500 | ||
|---|---|---|---|
| 001 | ZDB-2-SBL-978-3-031-52864-4 | ||
| 003 | DE-He213 | ||
| 005 | 20240329105033.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 240329s2024 sz | o |||| 0|eng d | ||
| 020 | |a 9783031528644 |9 978-3-031-52864-4 | ||
| 024 | 7 | |a 10.1007/978-3-031-52864-4 |2 doi | |
| 050 | 4 | |a RS1-441 | |
| 072 | 7 | |a MQP |2 bicssc | |
| 072 | 7 | |a MED072000 |2 bisacsh | |
| 072 | 7 | |a MQP |2 thema | |
| 082 | 7 | |a 615.1 |2 23 | |
| 245 | 1 | 0 | |a Drug Delivery and Targeting |h [electronic resource] / |c edited by Monika Schäfer-Korting, Ulrich S. Schubert. |
| 250 | |a 1st ed. 2024. | ||
| 264 | 1 | |a Cham : |b Springer International Publishing : |b Imprint: Springer, |c 2024. | |
| 300 | |a 1 Online-Ressource (X, 411 p. 70 illus.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a text file |b PDF |2 rda | ||
| 490 | 1 | |a Handbook of Experimental Pharmacology, |x 1865-0325 ; |v 284 | |
| 505 | 0 | |a Part I. Nanoparticles and other Advanced Technologies -- Knowledge-based design of multi-functional polymer-based nanoparticles -- Stimuli-responsive non-viral nanoparticles for gene delivery -- Sustainability in drug and nano-particle processing -- Advanced formulation approaches for proteins -- Microneedles and polymer films - delivery of peptides, proteins and nucleic acids -- Advances in vaccine delivery enhancers - small molecules and nanomaterials -- Biodegradable long acting injectables: Platform technology and industrial challenges -- Part II. Visualization Technologies -- Visualization of Nano-carriers and Drugs in Cells and Tissue -- Characterization of drug delivery systems by transmission electron microscopy -- Part III. Target Specific Delivery -- Blood-brain barrier-crossing strategies for improved treatment of CNS disorders -- Interactions of nano-systems with immune cells and cancer cells - a roadmap to clinical use?- Progress in ocular drug delivery: challenges and constraints -- New therapeutic options in pulmonal diseases - sphingolipids and sphingolipid metabolism -- Molecular therapeutics for pulmonary diseases - the need for drug targeting -- Delivery of mitochondrial RNA -- Part IV. Concerted Actions - Thinking the Drug from the Beginning -- ATMP formulations and delivery -- Preclinical testing and approval of ATMP -- Looking to the future - drug delivery in the prophylaxis and therapy of severe and chronic diseases. | |
| 520 | |a Since the publication of the Handbook of Experimental Pharmacology Vol. 197 in 2010 there have been important advances in drug development, drug delivery and - more recently - drug targeting. This is in particular relevant with the new generation of drugs acting on the immune system and tumors. These are quite often accompanied by major adverse reactions. Safe therapy is, therefore, an important area of research, in particular in chronic diseases and in persons of old age. In addition, the Covid-19 pandemic has brought renewed attention to vaccinations against viral infections, and mRNA vaccines have been tested for vaccination in tumor therapy, too. Vaccine delivery has stimulated important research on carriers which may pave the way for other applications and enhance a path to e.g. CRISPR-cas therapy. | ||
| 650 | 0 | |a Pharmacy. | |
| 650 | 0 | |a Pharmacology. | |
| 650 | 0 | |a Medicine |x Research. | |
| 650 | 0 | |a Biology |x Research. | |
| 650 | 0 | |a Clinical medicine |x Research. | |
| 650 | 0 | |a Pharmacovigilance. | |
| 650 | 1 | 4 | |a Pharmacy. |
| 650 | 2 | 4 | |a Pharmacology. |
| 650 | 2 | 4 | |a Translational Research. |
| 650 | 2 | 4 | |a Clinical Research. |
| 650 | 2 | 4 | |a Drug Safety and Pharmacovigilance. |
| 700 | 1 | |a Schäfer-Korting, Monika. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a Schubert, Ulrich S. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 710 | 2 | |a SpringerLink (Online service) | |
| 773 | 0 | |t Springer Nature eBook | |
| 776 | 0 | 8 | |i Printed edition: |z 9783031528637 |
| 776 | 0 | 8 | |i Printed edition: |z 9783031528651 |
| 776 | 0 | 8 | |i Printed edition: |z 9783031528668 |
| 830 | 0 | |a Handbook of Experimental Pharmacology, |x 1865-0325 ; |v 284 | |
| 966 | 4 | 0 | |l DE-355 |p ZDB-2-SBL |q UBG_PDA_SBL |u https://doi.org/10.1007/978-3-031-52864-4 |3 Volltext |
| 912 | |a ZDB-2-SBL | ||
| 912 | |a ZDB-2-SXB | ||
| 950 | |a Biomedical and Life Sciences (SpringerNature-11642) | ||
| 950 | |a Biomedical and Life Sciences (R0) (SpringerNature-43708) | ||
| 912 | |a ZDB-2-SBL | ||
| 049 | |a DE-355 | ||
Datensatz im Suchindex
| DE-BY-UBR_katkey | ZDB-2-SBL-978-3-031-52864-4 |
|---|---|
| _version_ | 1835726565815615488 |
| adam_text | |
| any_adam_object | |
| author2 | Schäfer-Korting, Monika Schubert, Ulrich S. |
| author2_role | edt edt |
| author2_variant | m s k msk u s s us uss |
| author_corporate | SpringerLink (Online service) |
| author_corporate_role | |
| author_facet | Schäfer-Korting, Monika Schubert, Ulrich S. SpringerLink (Online service) |
| building | Verbundindex |
| bvnumber | localUBR |
| callnumber-first | R - Medicine |
| callnumber-label | RS1-441 |
| callnumber-raw | RS1-441 |
| callnumber-search | RS1-441 |
| callnumber-sort | RS 11 3441 |
| callnumber-subject | RS - Pharmacy |
| collection | ZDB-2-SBL ZDB-2-SXB |
| contents | Part I. Nanoparticles and other Advanced Technologies -- Knowledge-based design of multi-functional polymer-based nanoparticles -- Stimuli-responsive non-viral nanoparticles for gene delivery -- Sustainability in drug and nano-particle processing -- Advanced formulation approaches for proteins -- Microneedles and polymer films - delivery of peptides, proteins and nucleic acids -- Advances in vaccine delivery enhancers - small molecules and nanomaterials -- Biodegradable long acting injectables: Platform technology and industrial challenges -- Part II. Visualization Technologies -- Visualization of Nano-carriers and Drugs in Cells and Tissue -- Characterization of drug delivery systems by transmission electron microscopy -- Part III. Target Specific Delivery -- Blood-brain barrier-crossing strategies for improved treatment of CNS disorders -- Interactions of nano-systems with immune cells and cancer cells - a roadmap to clinical use?- Progress in ocular drug delivery: challenges and constraints -- New therapeutic options in pulmonal diseases - sphingolipids and sphingolipid metabolism -- Molecular therapeutics for pulmonary diseases - the need for drug targeting -- Delivery of mitochondrial RNA -- Part IV. Concerted Actions - Thinking the Drug from the Beginning -- ATMP formulations and delivery -- Preclinical testing and approval of ATMP -- Looking to the future - drug delivery in the prophylaxis and therapy of severe and chronic diseases. |
| dewey-full | 615.1 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.1 |
| dewey-search | 615.1 |
| dewey-sort | 3615.1 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| edition | 1st ed. 2024. |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04399nam a22005895i 4500</leader><controlfield tag="001">ZDB-2-SBL-978-3-031-52864-4</controlfield><controlfield tag="003">DE-He213</controlfield><controlfield tag="005">20240329105033.0</controlfield><controlfield tag="007">cr nn 008mamaa</controlfield><controlfield tag="008">240329s2024 sz | o |||| 0|eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783031528644</subfield><subfield code="9">978-3-031-52864-4</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-3-031-52864-4</subfield><subfield code="2">doi</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RS1-441</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MQP</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED072000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MQP</subfield><subfield code="2">thema</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">615.1</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Drug Delivery and Targeting</subfield><subfield code="h">[electronic resource] /</subfield><subfield code="c">edited by Monika Schäfer-Korting, Ulrich S. Schubert.</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1st ed. 2024.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cham :</subfield><subfield code="b">Springer International Publishing :</subfield><subfield code="b">Imprint: Springer,</subfield><subfield code="c">2024.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (X, 411 p. 70 illus.) </subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="347" ind1=" " ind2=" "><subfield code="a">text file</subfield><subfield code="b">PDF</subfield><subfield code="2">rda</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Handbook of Experimental Pharmacology,</subfield><subfield code="x">1865-0325 ;</subfield><subfield code="v">284</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Part I. Nanoparticles and other Advanced Technologies -- Knowledge-based design of multi-functional polymer-based nanoparticles -- Stimuli-responsive non-viral nanoparticles for gene delivery -- Sustainability in drug and nano-particle processing -- Advanced formulation approaches for proteins -- Microneedles and polymer films - delivery of peptides, proteins and nucleic acids -- Advances in vaccine delivery enhancers - small molecules and nanomaterials -- Biodegradable long acting injectables: Platform technology and industrial challenges -- Part II. Visualization Technologies -- Visualization of Nano-carriers and Drugs in Cells and Tissue -- Characterization of drug delivery systems by transmission electron microscopy -- Part III. Target Specific Delivery -- Blood-brain barrier-crossing strategies for improved treatment of CNS disorders -- Interactions of nano-systems with immune cells and cancer cells - a roadmap to clinical use?- Progress in ocular drug delivery: challenges and constraints -- New therapeutic options in pulmonal diseases - sphingolipids and sphingolipid metabolism -- Molecular therapeutics for pulmonary diseases - the need for drug targeting -- Delivery of mitochondrial RNA -- Part IV. Concerted Actions - Thinking the Drug from the Beginning -- ATMP formulations and delivery -- Preclinical testing and approval of ATMP -- Looking to the future - drug delivery in the prophylaxis and therapy of severe and chronic diseases.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Since the publication of the Handbook of Experimental Pharmacology Vol. 197 in 2010 there have been important advances in drug development, drug delivery and - more recently - drug targeting. This is in particular relevant with the new generation of drugs acting on the immune system and tumors. These are quite often accompanied by major adverse reactions. Safe therapy is, therefore, an important area of research, in particular in chronic diseases and in persons of old age. In addition, the Covid-19 pandemic has brought renewed attention to vaccinations against viral infections, and mRNA vaccines have been tested for vaccination in tumor therapy, too. Vaccine delivery has stimulated important research on carriers which may pave the way for other applications and enhance a path to e.g. CRISPR-cas therapy.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmacy.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmacology.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Medicine</subfield><subfield code="x">Research.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Biology</subfield><subfield code="x">Research.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Clinical medicine</subfield><subfield code="x">Research.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmacovigilance.</subfield></datafield><datafield tag="650" ind1="1" ind2="4"><subfield code="a">Pharmacy.</subfield></datafield><datafield tag="650" ind1="2" ind2="4"><subfield code="a">Pharmacology.</subfield></datafield><datafield tag="650" ind1="2" ind2="4"><subfield code="a">Translational Research.</subfield></datafield><datafield tag="650" ind1="2" ind2="4"><subfield code="a">Clinical Research.</subfield></datafield><datafield tag="650" ind1="2" ind2="4"><subfield code="a">Drug Safety and Pharmacovigilance.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schäfer-Korting, Monika.</subfield><subfield code="e">editor.</subfield><subfield code="4">edt</subfield><subfield code="4">http://id.loc.gov/vocabulary/relators/edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schubert, Ulrich S.</subfield><subfield code="e">editor.</subfield><subfield code="4">edt</subfield><subfield code="4">http://id.loc.gov/vocabulary/relators/edt</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">SpringerLink (Online service)</subfield></datafield><datafield tag="773" ind1="0" ind2=" "><subfield code="t">Springer Nature eBook</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Printed edition:</subfield><subfield code="z">9783031528637</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Printed edition:</subfield><subfield code="z">9783031528651</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Printed edition:</subfield><subfield code="z">9783031528668</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Handbook of Experimental Pharmacology,</subfield><subfield code="x">1865-0325 ;</subfield><subfield code="v">284</subfield></datafield><datafield tag="966" ind1="4" ind2="0"><subfield code="l">DE-355</subfield><subfield code="p">ZDB-2-SBL</subfield><subfield code="q">UBG_PDA_SBL</subfield><subfield code="u">https://doi.org/10.1007/978-3-031-52864-4</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SBL</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SXB</subfield></datafield><datafield tag="950" ind1=" " ind2=" "><subfield code="a">Biomedical and Life Sciences (SpringerNature-11642)</subfield></datafield><datafield tag="950" ind1=" " ind2=" "><subfield code="a">Biomedical and Life Sciences (R0) (SpringerNature-43708)</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SBL</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield></record></collection> |
| id | ZDB-2-SBL-978-3-031-52864-4 |
| illustrated | Not Illustrated |
| indexdate | 2025-06-23T13:27:57Z |
| institution | BVB |
| isbn | 9783031528644 |
| issn | 1865-0325 ; |
| language | English |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 Online-Ressource (X, 411 p. 70 illus.) |
| psigel | ZDB-2-SBL UBG_PDA_SBL ZDB-2-SBL ZDB-2-SXB |
| publishDate | 2024 |
| publishDateSearch | 2024 |
| publishDateSort | 2024 |
| publisher | Springer International Publishing : Imprint: Springer, |
| record_format | marc |
| series | Handbook of Experimental Pharmacology, |
| series2 | Handbook of Experimental Pharmacology, |
| spelling | Drug Delivery and Targeting [electronic resource] / edited by Monika Schäfer-Korting, Ulrich S. Schubert. 1st ed. 2024. Cham : Springer International Publishing : Imprint: Springer, 2024. 1 Online-Ressource (X, 411 p. 70 illus.) text txt rdacontent computer c rdamedia online resource cr rdacarrier text file PDF rda Handbook of Experimental Pharmacology, 1865-0325 ; 284 Part I. Nanoparticles and other Advanced Technologies -- Knowledge-based design of multi-functional polymer-based nanoparticles -- Stimuli-responsive non-viral nanoparticles for gene delivery -- Sustainability in drug and nano-particle processing -- Advanced formulation approaches for proteins -- Microneedles and polymer films - delivery of peptides, proteins and nucleic acids -- Advances in vaccine delivery enhancers - small molecules and nanomaterials -- Biodegradable long acting injectables: Platform technology and industrial challenges -- Part II. Visualization Technologies -- Visualization of Nano-carriers and Drugs in Cells and Tissue -- Characterization of drug delivery systems by transmission electron microscopy -- Part III. Target Specific Delivery -- Blood-brain barrier-crossing strategies for improved treatment of CNS disorders -- Interactions of nano-systems with immune cells and cancer cells - a roadmap to clinical use?- Progress in ocular drug delivery: challenges and constraints -- New therapeutic options in pulmonal diseases - sphingolipids and sphingolipid metabolism -- Molecular therapeutics for pulmonary diseases - the need for drug targeting -- Delivery of mitochondrial RNA -- Part IV. Concerted Actions - Thinking the Drug from the Beginning -- ATMP formulations and delivery -- Preclinical testing and approval of ATMP -- Looking to the future - drug delivery in the prophylaxis and therapy of severe and chronic diseases. Since the publication of the Handbook of Experimental Pharmacology Vol. 197 in 2010 there have been important advances in drug development, drug delivery and - more recently - drug targeting. This is in particular relevant with the new generation of drugs acting on the immune system and tumors. These are quite often accompanied by major adverse reactions. Safe therapy is, therefore, an important area of research, in particular in chronic diseases and in persons of old age. In addition, the Covid-19 pandemic has brought renewed attention to vaccinations against viral infections, and mRNA vaccines have been tested for vaccination in tumor therapy, too. Vaccine delivery has stimulated important research on carriers which may pave the way for other applications and enhance a path to e.g. CRISPR-cas therapy. Pharmacy. Pharmacology. Medicine Research. Biology Research. Clinical medicine Research. Pharmacovigilance. Translational Research. Clinical Research. Drug Safety and Pharmacovigilance. Schäfer-Korting, Monika. editor. edt http://id.loc.gov/vocabulary/relators/edt Schubert, Ulrich S. editor. edt http://id.loc.gov/vocabulary/relators/edt SpringerLink (Online service) Springer Nature eBook Printed edition: 9783031528637 Printed edition: 9783031528651 Printed edition: 9783031528668 |
| spellingShingle | Drug Delivery and Targeting Handbook of Experimental Pharmacology, Part I. Nanoparticles and other Advanced Technologies -- Knowledge-based design of multi-functional polymer-based nanoparticles -- Stimuli-responsive non-viral nanoparticles for gene delivery -- Sustainability in drug and nano-particle processing -- Advanced formulation approaches for proteins -- Microneedles and polymer films - delivery of peptides, proteins and nucleic acids -- Advances in vaccine delivery enhancers - small molecules and nanomaterials -- Biodegradable long acting injectables: Platform technology and industrial challenges -- Part II. Visualization Technologies -- Visualization of Nano-carriers and Drugs in Cells and Tissue -- Characterization of drug delivery systems by transmission electron microscopy -- Part III. Target Specific Delivery -- Blood-brain barrier-crossing strategies for improved treatment of CNS disorders -- Interactions of nano-systems with immune cells and cancer cells - a roadmap to clinical use?- Progress in ocular drug delivery: challenges and constraints -- New therapeutic options in pulmonal diseases - sphingolipids and sphingolipid metabolism -- Molecular therapeutics for pulmonary diseases - the need for drug targeting -- Delivery of mitochondrial RNA -- Part IV. Concerted Actions - Thinking the Drug from the Beginning -- ATMP formulations and delivery -- Preclinical testing and approval of ATMP -- Looking to the future - drug delivery in the prophylaxis and therapy of severe and chronic diseases. Pharmacy. Pharmacology. Medicine Research. Biology Research. Clinical medicine Research. Pharmacovigilance. Translational Research. Clinical Research. Drug Safety and Pharmacovigilance. |
| title | Drug Delivery and Targeting |
| title_auth | Drug Delivery and Targeting |
| title_exact_search | Drug Delivery and Targeting |
| title_full | Drug Delivery and Targeting [electronic resource] / edited by Monika Schäfer-Korting, Ulrich S. Schubert. |
| title_fullStr | Drug Delivery and Targeting [electronic resource] / edited by Monika Schäfer-Korting, Ulrich S. Schubert. |
| title_full_unstemmed | Drug Delivery and Targeting [electronic resource] / edited by Monika Schäfer-Korting, Ulrich S. Schubert. |
| title_short | Drug Delivery and Targeting |
| title_sort | drug delivery and targeting |
| topic | Pharmacy. Pharmacology. Medicine Research. Biology Research. Clinical medicine Research. Pharmacovigilance. Translational Research. Clinical Research. Drug Safety and Pharmacovigilance. |
| topic_facet | Pharmacy. Pharmacology. Medicine Research. Biology Research. Clinical medicine Research. Pharmacovigilance. Translational Research. Clinical Research. Drug Safety and Pharmacovigilance. |
| work_keys_str_mv | AT schaferkortingmonika drugdeliveryandtargeting AT schubertulrichs drugdeliveryandtargeting AT springerlinkonlineservice drugdeliveryandtargeting |